Torsten Buergermeister has been appointed Chief Financial Officer (CFO) of VERAXA Biotech, based in Heidelberg, Germany.
Torsten Buergermeister
Buergermeister joins VERAXA from Molecular Health, an international Precision Medicine company where he had global responsibilities as Senior Vice President of Finance.
“Torsten brings excellent financial managing skills with a very good knowledge of biotech and related capital markets,” said Dr. Christoph Antz, CEO of VERAXA. “We are excited to have him join our management team.”